From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
January 29, 2018
Philadelphia, PA, January 29, 2018 – IntegriChain, a leading healthcare technology company delivering a comprehensive data and analytics platform covering all core elements of access—Market Access, Patient Access, and Distribution, today announced the opening of its new Access Management Operations center for claims adjudication. This new facility will house the industry’s leading contract operations offering for government and commercial rebate processing and chargeback reconciliation in Ambler, PA, a suburb of Philadelphia. Additionally, IntegriChain announced that its SOC compliance report is available upon request.
“Through our Access Management Operations outsourcing services, our Market Access team helps leading small and midsize bio/pharma manufacturers reduce risk, ensure compliance, and increase net profits while managing the ever-changing complexities of contract management, processing, and analysis,” said IntegriChain CEO Kevin Leininger. “We are a trusted Access Management partner to more than 40 bio/pharma manufacturers and growing, able to rapidly scale in response to a launch or acquisition and process thousands and thousands of claims each month—all accurately, securely, and on time. Importantly, beyond this outstanding BPO offering, we are the only company utilizing world-class data science to integrate disparate Market Access, Patient Access, and Distribution data flows and deliver analytics and actionable insights that allow bio/pharma suppliers to improve the patient journey.”
About IntegriChain Access Management IntegriChain Access Management allows bio/pharma manufacturers to scale their commercial operations through outsourcing of commercial and government contract and pricing functions. IntegriChain provides manufacturers with comprehensive services for Commercial Managed Care, Part D, Tricare, Medicaid, health system, and 340B contracts including contract management, detailed script level claim validation, rebate payment processing, dispute management, and government price reporting. IntegriChain Access Management also delivers chargeback validation and chargeback revenue leakage insights including contract eligibility, membership verification, price checks, and quantity validation by uniquely leveraging channel sales and inventory data. IntegriChain also offers a full suite of Patient Access, Distribution, and Advisory solutions to optimize government and payer contracts.
About IntegriChain IntegriChain is a leading healthcare technology company for bio/pharma manufacturers, uniquely employing world-class data science to integrate all core elements of access data—Market Access, Patient Access, and Distribution—delivering analytics and insights that help patients start and stay on therapy. IntegriChain’s comprehensive commercial and access data and analytics platform produces insights on bio/pharma therapies throughout their market life, from the successful launch of new innovative therapies to more efficient and service-oriented channel models for mature product categories. Today IntegriChain is the trusted partner for all top-10, 16 of the top-20, and more than 80 other bio/pharma manufacturers, totaling more than $250 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
